Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Galasko, D' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 90 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gould, R; Abramson, I; Galasko, D; Salmon, D
      Rate of cognitive change in Alzheimer's disease: Methodological approachesusing random effects models

      JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
    2. Galasko, D
      Biological markers and the treatment of Alzheimer's disease

      JOURNAL OF MOLECULAR NEUROSCIENCE
    3. Galasko, D
      Alzheimer's disease and dementia - Preface

      CLINICS IN GERIATRIC MEDICINE
    4. Galasko, D
      New approaches to diagnose and treat Alzheimer's disease - A glimpse of the future

      CLINICS IN GERIATRIC MEDICINE
    5. Zhukareva, V; Vogelsberg-Ragaglia, V; Van Deerlin, VMD; Bruce, J; Shuck, T; Grossman, M; Clark, CM; Arnold, SE; Masliah, E; Galasko, D; Trojanowski, JQ; Lee, VMY
      Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia

      ANNALS OF NEUROLOGY
    6. Galasko, D
      Dr. Wigbert (Bert) Wiederholt - Obituary

      NEUROEPIDEMIOLOGY
    7. Rockenstein, E; Hansen, LA; Mallory, M; Trojanowski, JQ; Galasko, D; Masliah, E
      Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease

      BRAIN RESEARCH
    8. Poorkaj, P; Grossman, M; Steinbart, E; Payami, H; Sadovnick, A; Nochlin, D; Tabira, T; Trojanowski, JQ; Borson, S; Galasko, D; Reich, S; Quinn, B; Schellenberg, G; Bird, TD
      Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia

      ARCHIVES OF NEUROLOGY
    9. Poorkaj, P; Tsuang, D; Wijsman, E; Steinbart, E; Garruto, RM; Craig, UK; Chapman, NH; Anderson, L; Bird, TD; Plato, CC; Perl, DP; Weiderholt, W; Galasko, D; Schellenberg, GD
      TAU as a susceptibility gene for amyotropic lateral sclerosis-parkinsonismdementia complex of Guam

      ARCHIVES OF NEUROLOGY
    10. Vanmechelen, E; Van Kerschaver, E; Blennow, K; De Deyn, PP; Galasko, D; Parnetti, L; Sindic, CJM; Arai, H; Riemenschneider, M; Hampel, H; Pottel, H; Valgaeren, A; Hulstaert, F; Vanderstichele, H
      CSF-phospho-tau (181P) as a promising marker for discriminating Alzheimer's disease from dementia with Lewy bodies

      ALZHEIMER'S DISEASE
    11. Samuel, W; Caligiuri, M; Galasko, D; Lacro, J; Marini, M; McClure, FS; Warren, K; Jeste, DV
      Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: A preliminary study

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    12. Rockwell, E; Choure, J; Galasko, D; Olichney, J; Jeste, DV
      Psychopathology at initial diagnosis in dementia with Lewy bodies versus Alzheimer disease: Comparison of matched groups with autopsy-confirmed diagnoses

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    13. Babikian, V; Licata-Gehr, E; Joseph, LN; Bailey, P; Boyle, R; MacDougall, A; MacLean, G; Wheelock, WB; Kolyvas, G; Banas, T; Wissman, MA; Heckaman, JD; Porter, MA; Bhat, MH; Later, PE; Wissmann, SD; Ottinger, CJ; Stevens, JC; Plant, R; Chang, FL; Beatty, J; Beatty, TW; Cohen, SB; Vasquez, AB; Schmidt, DW; Allen, T; Bellavance, A; Hebert, L; Berger, L; Filatrault, R; Nasredding, Z; Trottier, AG; Duplessis, M; Maison, FG; Ninkovic, S; Berman, B; Yipelkonen, M; Miskin, BM; Shaivitz, SA; Benavente, O; Bruce, G; Solomen, D; Sherman, D; Hart, R; Kanter-Carolin, M; Lalonde, DR; Rogers, D; Bruce, G; Leonard, A; Brott, T; Spilker, J; Broderick, J; Kothari, R; Panicoli, A; Sauerbeck, L; Miller, R; Clark, WM; Deely, SM; Fisher, S; Lutsep, H; Quinn, J; Crawford, J; Egan, R; Nesbit, G; Al-Azzaz, A; Earley, C; Herr, M; Michel, H; Dike, G; Maragakis, N; Polydefkis, M; Wagner, K; Wang, M; Rusa, R; Jones, C; Kerr, D; Moo, L; Pardo, C; Silverman, I; Hoffman, J; Diebert, E; Jinnah, H; York, J; Hoke, A; Vega-Bermudez, F; Comi, A; Hillis, A; Rich, J; Ervin, J; Bryan, C; Allen, AA; Kelley, GB; Perll, MF; Box, MS; Robles, LH; Zwibelman, JS; Hopewell, DK; Ryan, ME; Wendland, RT; Feinberg, W; Coull, B; Rose-Taylor, D; Ahern, G; Anderson, LR; Keim, S; Sherman, S; Rose-Taylor, D; Haley, EC; Morris, A; Ahern, K; Johnston, K; Solenski, N; Nathan, B; Bleck, T; Worrall, B; Leszczyszyn, D; Hemstreet, M; Kiely, J; Burns, T; Klein, C; Cail, W; Huff, S; Quinn, J; Armstrong, R; Provencio, J; Snider, R; Van Gerpen, J; Hsu, C; Duke, L; Banet, G; Choi, J; Lee, JM; Lowenkopf, T; Innes, G; Metcalf, C; Huang, P; Rumball, C; Miller, B; Haegert, J; Holmes, A; Oldring, B; MacNab, J; Grosch, R; Deady, B; Street, R; O'Brien, R; Vertesi, L; Erhardt, G; Finkler, J; Tessler, C; Glazer, S; Noseworthy, R; Knazen, M; MacDonald, P; Smyth, A; Karp, J; Phillips, B; Spiegel, A; Bowman, SC; Hampsey, JP; Habib, MW; Schroeder, T; Stopnytsky, K; Kertecz, A; Piotrowski, S; Cooper, P; Lyden, P; Rapp, K; Jackson, C; Ellis, R; Noack, H; Sabbagh, M; Galasko, D; Rapp, K; Kelly, N; Werner, J; Chang, CL; Morris, DT; Pusek, S; Hinn, A; Ma, J; Bernard, E; Phillips, S; Reidy, Y; Gubitz, G; Tanha, F; Leckey, R; Ansell, J; Darvesh, S; Aguilar, E; Pullicino, P; Starr, S; Munschauer, FE; Ross, DB; Norris, D; Steinberg, J; Zaret, B; Maniar, M; Sacco, RL; Boden-Albala, B; Jimenez, M; Mohr, JP; Kargman, D; Marshall, R; Elkind, MS; Roberts, K; Gan, R; Shipley, N; Aboumatar, S; Greene, R; Shuaib, A; Kadribasic, E; Keegan, M; Stewart, B; Khaan, K; Shuaib, A; Dean, TR; Richardson, P; Moussavian, M; Faloriji, W; Johnson, M; Levin, Z; Silliman, S; Fuqua, PS; Berger, A; Najjar, S; Schwartz, R; Solomon, DH; Limon, L; Hart, RG; Sherman, DG; Carolin, MCK; Lalonde, DR; Benavente, O; Starkman, S; Schubert, GB; Dobkin, B; Saver, J; Vespa, P; Alger, J; Teitelbaum, J; Lachance, N; Robillard, A; Lachapelle, J; Boileau, J; Rousseau, S; Roy, L; Laplante, P; Thurston, S; McGee, JR; Lutz, MA; McGee, FE; Harris, JK; White, RJ; O'Bannon, JM; Brush, JJ; Cohen, RJ; Smith, TA; Mathe, SA; Karner, SF; Worthington, AK; Deel, JG; Tong, D; Hock, N; Albers, G; O'Brien, M; Woofenden, A; Yenari, M; Freyberg, S; Guro, G; Hock, N; Tuhrim, S; Augustine, S; Weinberger, J; Horowitz, D; Sheinart, K; Schonewille, W; Atlas, S; Veloso, F; Reid, M; Adaikari, K; Gebhardt, V; Nair, CPV; Wang, D; Vrabel, D; McLean, J; Kumar, J; Garwacki, D; Roda, M; Hui, E; Coyner, J; Vrabel, D; Honings, D; Rose, J; Sladana, R; Wechsler, L; Yasko, L; Knepper, L; Massaro, L; Graham, S; Larkin, G; Ulicny, T; Yonas, H; Barch, C; Lin, H; Brader, E; Berkey, K; Ludovici, J; Kaufmann, A; De Cesare, S; Hodgdon, A; MacLeod, B; Thompson, D; Piatkowski, S; O'Toole, K; Yasko, L; Ilkhanipour, K; Maenza, R; Mathias, S; Thulborn, K; Jungreis, C; Cockley, P; Corsello, G; Ammon, C; Rasheed, A; Weston, L; Bourque, G; Silverberg, D; Harper, B; Robinson, D; MacEachern, M; Williams, AD; Roth, R; Rice, M; Hogan, J; Pellegrino, TR; Holland, MT; Lanoue, RJ; Redding, A; Handler, J; Haley, EC; Alves, WM; Elder, L; Davenport, K; McClure, K; Knowlton, S; Cuccia, E; Maupin, K; Lotts, M; Hund, M; Shelleck, K; Szewc, T; Cail, W; Wagner, G; Gates, K; Earley, C; Haley, EC; Johnston, KC; Sacco, RL; Schuaib, A; Snipes, R; Wang, DZ; Brass, LM; Clark, WR; Grotta, JC; Harrison, M; McIntyre, N; Zimmerman, H; Wellcome, G; Snipes, R; Watson, D; Ordronneau, P; Hoke, F; Ko, WJ; Clayton, L; EnneyO' Mara, L; Johnson, J; Orander, C; Card, B; Green, S
      Phase II studies of the glycine antagonist GV150526 in acute stroke - The North American experience

      STROKE
    14. Paulsen, JS; Salmon, DP; Thal, LJ; Romero, R; Weisstein-Jenkins, C; Galasko, D; Hofstetter, CR; Thomas, R; Grant, I; Jeste, DV
      Incidence of and risk factors for hallucinations and delusions in patientswith probable AD

      NEUROLOGY
    15. Bondi, MW; Salmon, DP; Galasko, D; Thomas, RG; Thal, LJ
      Neuropsychological function and Apolipoprotein E genotype in the preclinical detection of Alzheimer's disease

      PSYCHOLOGY AND AGING
    16. Moriearty, PL; Seubert, P; Galasko, D; Markwell, S; Unni, L; Vicari, S; Becker, RE
      Effects of time and cholinesterase inhibitor treatment on multiple cerebrospinal fluid parameters in Alzheimer's disease

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    17. Altschuler, EL; Wisdom, SB; Stone, L; Foster, C; Galasko, D; Llewellyn, DME; Ramachandran, VS
      Rehabilitation of hemiparesis after stroke with a mirror

      LANCET
    18. Teter, B; Xu, PT; Gilbert, JR; Roses, AD; Galasko, D; Cole, GM
      Human apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal culture

      JOURNAL OF NEUROCHEMISTRY
    19. Sunderland, T; Wolozin, B; Galasko, D; Levy, J; Dukoff, R; Bahro, M; Lasser, R; Motter, R; Lehtimaki, T; Seubert, P
      Longitudinal stability of CSF tau levels in Alzheimer patients

      BIOLOGICAL PSYCHIATRY
    20. Clark, CM; Sheppard, L; Fillenbaum, GG; Galasko, D; Morris, JC; Koss, E; Mohs, R; Heyman, A
      Variability in annual mini-mental state examination score in patients withprobable Alzheimer disease - A clinical perspective of data from the consortium to establish a registry for Alzheimer's disease

      ARCHIVES OF NEUROLOGY
    21. Galasko, D
      Cerebrospinal fluid opens a window on Alzheimer disease

      ARCHIVES OF NEUROLOGY
    22. Lambert, JC; Berr, C; Pasquier, F; Delacourte, A; Frigard, B; Cottel, D; Perez-Tur, J; Mouroux, V; Mohr, M; Cecyre, D; Galasko, D; Lendon, C; Poirier, J; Hardy, J; Mann, D; Amouyel, P; Chartier-Harlin, MC
      The risk of developing Alzheimer's disease associated with the APOE promoter polymorphisms

      ALZHEIMER'S DISEASE AND RELATED DISORDERS
    23. Galasko, D
      An integrated approach to the management of Alzheimer's disease: assessingcognition, function and behaviour

      EUROPEAN JOURNAL OF NEUROLOGY
    24. LAMBERT JC; BERR C; PASQUIER F; DELACOURTE A; FRIGARD B; COTTEL D; PEREZTUR J; MOUROUX V; MOHR M; CECYRE D; GALASKO D; LENDON C; POIRIER J; HARDY J; MANN D; AMOUYEL P; CHARTIERHARLIN MC
      PRONOUNCED IMPACT OF TH1 E47CS MUTATION COMPARED WITH -491 AT MUTATION ON NEURAL APOE GENE-EXPRESSION AND RISK OF DEVELOPING ALZHEIMERS-DISEASE/

      Human molecular genetics (Print)
    25. ELLIS RJ; SEUBERT P; MOTTER R; GALASKO D; DEUTSCH R; HEATON RK; HEYES MP; MCCUTCHAN JA; GRANT I
      CEREBROSPINAL-FLUID TAU-PROTEIN IS NOT ELEVATED IN HIV-ASSOCIATED NEUROLOGIC DISEASE IN HUMANS

      Neuroscience letters
    26. GALASKO D
      CEREBROSPINAL-FLUID LEVELS OF A-BETA-42 AND TAU - POTENTIAL MARKERS OF ALZHEIMERS-DISEASE

      Journal of neural transmission. Supplementum
    27. GALASKO D
      CSF-TAU AND A-BETA-42 - LOGICAL BIOMARKERS FOR ALZHEIMERS-DISEASE

      Neurobiology of aging
    28. GALASKO D
      THE ROLE OF APOLIPOPROTEIN-E TESTING IN THE DIAGNOSIS OF ALZHEIMERS-DISEASE

      Western journal of medicine
    29. OLICHNEY JM; GALASKO D; SALMON DP; HOFSTETTER CR; KATZMAN R; THAL LJ
      COGNITIVE DECLINE IS FASTER IN LEWY BODY VARIANT THAN IN ALZHEIMERS-DISEASE

      Neurology
    30. DAVIS RE; MILLER S; HERRNSTADT C; GHOSH SS; FAHY E; SHINOBU LA; GALASKO D; THAL LJ; BEAL MF; HOWELL N; PARKER WD
      MUTATIONS IN MITOCHONDRIA CYTOCHROME-C-OXIDASE GENES SEGREGATE WITH LATE-ONSET ALZHEIMER-DISEASE (VOL 94, PG 4526, 1997)

      Proceedings of the National Academy of Sciences of the United Statesof America
    31. LICASTRO F; DAVIS LJ; PEDRINI S; GALASKO D; MASLIAH E
      PROSTAGLANDIN-E2 INDUCED POLYMERIZATION OF HUMAN ALPHA-1-ANTICHYMOTRYPSIN AND SUPPRESSED ITS PROTEASE INHIBITORY ACTIVITY - IMPLICATIONS FOR ALZHEIMERS-DISEASE

      Biochemical and biophysical research communications (Print)
    32. GALASKO D; CHANG L; MOTTER R; CLARK CM; KAYE J; KNOPMAN D; THOMAS R; KHOLODENKO D; SCHENK D; LIEBERBURG I; MILLER B; GREEN R; BASHERAD R; KERTILES L; BOSS MA; SEUBERT P
      HIGH CEREBROSPINAL-FLUID TAU AND LOW AMYLOID BETA-42 LEVELS IN THE CLINICAL-DIAGNOSIS OF ALZHEIMER-DISEASE AND RELATION TO APOLIPOPROTEIN-EGENOTYPE

      Archives of neurology
    33. CONNOR DJ; SALMON DP; SANDY TJ; GALASKO D; HANSEN LA; THAL LJ
      COGNITIVE PROFILES OF AUTOPSY-CONFIRMED LEWY BODY VARIANT VS PURE ALZHEIMER-DISEASE

      Archives of neurology
    34. CONNOR DJ; SALMON DP; SANDY TJ; GALASKO D; HANSEN LA; THAL LJ
      COGNITIVE PROFILES OF AUTOSY-CONFIRMED LEWY BODY VARIANT VS PURE ALZHEIMER-DISEASE (VOL 55, PG 994, 1998)

      Archives of neurology
    35. LAMBERT JC; PEREZTUR J; DUPIRE MJ; GALASKO D; MANN D; AMOUYEL P; HARDY J; DELACOURTE A; CHARTIERHARLIN MC
      DISTORTION OF ALLELIC EXPRESSION OF APOLIPOPROTEIN-E IN ALZHEIMERS-DISEASE

      Human molecular genetics
    36. FERRIS SH; MACKELL JA; MOHS R; SCHNEIDER LS; GALASKO D; WHITEHOUSE PJ; SCHMITT FA; SANO M; THOMAS RG; ERNESTO C; GRUNDMAN M; SCHAFER K; THAL LJ
      A MULTICENTER EVALUATION OF NEW TREATMENT EFFICACY INSTRUMENTS FOR ALZHEIMERS-DISEASE CLINICAL-TRIALS - OVERVIEW AND GENERAL RESULTS

      Alzheimer disease and associated disorders
    37. GALASKO D; BENNETT D; SANO M; ERNESTO C; THOMAS R; GRUNDMAN M; FERRIS S
      AN INVENTORY TO ASSESS ACTIVITIES OF DAILY LIVING FOR CLINICAL-TRIALSIN ALZHEIMERS-DISEASE

      Alzheimer disease and associated disorders
    38. MACKELL JA; FERRIS SH; MOHS R; SCHNEIDER L; GALASKO D; WHITEHOUSE P; SCHMITT F; SANO M; THAL LJ
      MULTICENTER EVALUATION OF NEW INSTRUMENTS FOR ALZHEIMERS-DISEASE CLINICAL-TRIALS - SUMMARY OF RESULTS

      Alzheimer disease and associated disorders
    39. CONNOR DJ; SANDY TJ; SALMON DP; GALASKO D; THAL LH
      STRATEGIES OF WORD PRODUCTION IN AD, LBV AND ELDERLY CONTROLS

      Archives of clinical neuropsychology
    40. CROOK R; ELLIS R; SHANKS M; THAL LJ; PEREZTUR J; BAKER M; HUTTON M; HALTIA T; HARDY J; GALASKO D
      EARLY-ONSET ALZHEIMERS-DISEASE WITH A PRESENILIN-1 MUTATION AT THE SITE CORRESPONDING TO THE VOLGA GERMAN PRESENILIN-2 MUTATION

      Annals of neurology
    41. GALASKO D
      ASSESSMENT OF CSF LEVELS OF TAN PROTEIN IN PATIENTS WITH ALZHEIMERS-DISEASE AND MILD DEMENTIA - REPLY

      Neurology
    42. OLICHNEY JM; SABBAGH MN; HOFSTETTER CR; GALASKO D; GRUNDMAN M; KATZMAN R; THAL LJ
      THE IMPACT OF APOLIPOPROTEIN E4 ON CAUSE OF DEATH IN ALZHEIMERS-DISEASE

      Neurology
    43. PEAVY GM; SAMUEL W; SALMON DP; ELLIS RJ; GALASKO D; HANSEN LA
      NEUROPATHOLOGIC CORRELATES OF SPECIFIC COGNITIVE FUNCTIONS IN SEVERE ALZHEIMERS DEMENTIA

      Neurology
    44. OLICHNEY JM; HOFSTETTER CR; SALMON D; HANSEN L; GALASKO D; HEYMAN A; KATZMAN R; THAL LJ
      COGNITIVE DECLINE IS FASTER IN LEWY BODY VARIANT THAN IN ALZHEIMERS-DISEASE

      Neurology
    45. SEUBERT PA; MOTTER RN; SCHENK DB; LIEBERBURG IM; KHOLODENKO D; GALASKO D; THOMAS R; CHANG L; MILLER B; CLARK C; KNOPMAN DS; KAYE J; GREEN RC; KERTILES L; BASHIRZADEH R; BOSS MA
      APOE GENOTYPE INFLUENCES THE CSF LEVEL OF A-BETA-42 IN ALZHEIMERS-DISEASE

      Neurology
    46. GALASKO D; SEUBERT P; MOTTER R; SCHENK D; KHOLODENKO D; LIEBERBURG I; CHANG L; MILLER B; CLARK C; KAYE J; CAMICIOLI R; KNOPMAN D; GREEN RC; THOMAS R; KERTILES L; BOSS M
      CSF LEVELS OF A-BETA-432 AND TAU AS AIDS TO DIAGNOSING ALZHEIMERS-DISEASE

      Neurology
    47. GALASKO D; CLARK C; CHANG L; MILLER B; GREEN RC; MOTTER R; SEUBERT P
      ASSESSMENT OF CSF LEVELS OF TAN PROTEIN IN MILDLY DEMENTED PATIENTS WITH ALZHEIMERS-DISEASE

      Neurology
    48. DAVIS RE; MILLER S; HERRNSTADT C; GHOSH SS; FAHY E; SHINOBU LA; GALASKO D; THAL LJ; BEAL MF; HOWELL N; PARKER WD
      MUTATIONS IN MITOCHONDRIAL CYTOCHROME-C-OXIDASE GENES SEGREGATE WITH LATE-ONSET ALZHEIMER-DISEASE

      Proceedings of the National Academy of Sciences of the United Statesof America
    49. JOHNSON GVW; SEUBERT P; COX TM; MOTTER R; BROWN JP; GALASKO D
      THE TAU-PROTEIN IN HUMAN CEREBROSPINAL-FLUID IN ALZHEIMERS-DISEASE CONSISTS OF PROTEOLYTICALLY DERIVED FRAGMENTS

      Journal of neurochemistry
    50. BONDI MW; SALMON DP; GALASKO D; THAL LJ; SAITOH T
      NEUROPSYCHOLOGICAL FUNCTION AND THE APOLIPOPROTEIN-E IN NONDEMENTED OLDER ADULTS

      Clinical neuropsychologist
    51. SALMON DP; GALASKO D; HANSEN LA; MASLIAH E; BUTTERS N; THAL LJ; KATZMAN R
      NEUROPSYCHOLOGICAL DEFICITS ASSOCIATED WITH DIFFUSE LEWY BODY DISEASE

      Brain and cognition
    52. GALASKO D; KATZMAN R; SALMON DP; HANSEN L
      CLINICAL AND NEUROPATHOLOGICAL FINDINGS IN LEWY BODY DEMENTIAS

      Brain and cognition
    53. MCKEITH IG; GALASKO D; KOSAKA K; PERRY EK; DICKSON DW; HANSEN LA; SALMON DP; LOWE J; MIRRA SS; BYRNE EJ; LENNOX G; QUINN NP; EDWARDSON JA; INCE PG; BERGERON C; BURNS A; MILLER BL; LOVESTONE S; COLLERTON D; JANSEN ENH; BALLARD C; DEVOS RAI; WILCOCK GK; JELLINGER KA; PERRY RH
      CONSENSUS GUIDELINES FOR THE CLINICAL AND PATHOLOGICAL DIAGNOSIS OF DEMENTIA WITH LEWY BODIES (DLB) - REPORT OF THE CONSORTIUM ON DLB INTERNATIONAL WORKSHOP

      Neurology
    54. CHEN X; XIA Y; GRESHAM LS; MOLGAARD CA; THOMAS RG; GALASKO D; WIEDERHOLT WC; SAITOH T
      APOE AND CYP2D6 POLYMORPHISM WITH AND WITHOUT PARKINSONISM-DEMENTIA COMPLEX IN THE PEOPLE OF CHAMORRO, GUAM

      Neurology
    55. OLICHNEY JM; HANSEN LA; GALASKO D; SAITOH T; HOFSTETTER CR; KATZMAN R; THAL LJ
      THE APOLIPOPROTEIN-E EPSILON-4 ALLELE IS ASSOCIATED WITH INCREASED NEURITIC PLAQUES AND CEREBRAL AMYLOID ANGIOPATHY IN ALZHEIMERS-DISEASE AND LEWY BODY VARIANT

      Neurology
    56. GALASKO D; BENNETT D; ERNESTO C; THOMAS R; SANO M
      DEVELOPMENT OF A POOL OF ITEMS TO ASSESS ACTIVITIES OF DAILY LIVING IN CLINICAL-TRIALS FOR ALZHEIMERS-DISEASE

      Neurology
    57. OLICHNEY JM; SABBAGH MN; HOFSTETTER RC; GALASKO D; GRUNDMAN M; KATZMAN R; THAL L
      THE IMPACT OF APOLIPOPROTEIN E4 ON THE CAUSE OF DEATH IN ALZHEIMERS-DISEASE

      Neurology
    58. SEUBERT P; MOTTER R; SCHENK D; GREEN R; CHANG L; MILLER B; CLARK C; GALASKO D
      ELEVATION OF CSF-TAU IN EARLY-STAGE ALZHEIMERS-DISEASE

      Neurology
    59. DAVIS RE; MILLER S; HERRNSTADT C; GHOSH S; FAHY E; GALASKO D; THAL LJ; PARKER WD
      SPECIFIC POINT MUTATIONS IN MITOCHONDRIAL CYTOCHROME-OXIDASE GENES ARE ASSOCIATED WITH SPORADIC ALZHEIMERS-DISEASE

      Neurology
    60. GRUNDMAN M; PETERSEN RC; MORRIS JC; FERRIS S; SANO M; FARLOW MR; DOODY RS; GALASKO D; ERNESTO C; THOMAS RG; THAL LJ
      RATE OF DEMENTIA OF THE ALZHEIMER-TYPE (DAT) IN SUBJECTS WITH MILD COGNITIVE IMPAIRMENT

      Neurology
    61. KOSS E; EDLAND S; FILLENBAUM G; MOHS R; CLARK C; GALASKO D; MORRIS JC
      CLINICAL AND NEUROPSYCHOLOGICAL DIFFERENCES BETWEEN PATIENTS WITH EARLIER AND LATER ONSET OF ALZHEIMERS-DISEASE - A CERAD ANALYSIS .12.

      Neurology
    62. SAMUEL W; GALASKO D; MASLIAH E; HANSEN LA
      NEOCORTICAL LEWY-BODY COUNTS CORRELATE WITH DEMENTIA IN THE LEWY-BODYVARIANT OF ALZHEIMERS-DISEASE

      Journal of neuropathology and experimental neurology
    63. PEAVY GM; SALMON DP; RICE VA; GALASKO D; SAMUEL W; TAYLOR KI; ERNESTO C; BUTTERS N; THAL L
      NEUROPSYCHOLOGICAL ASSESSMENT OF SEVERELY DEMENTED ELDERLY - THE SEVERE COGNITIVE IMPAIRMENT PROFILE

      Archives of neurology
    64. COREYBLOOM J; GALASKO D
      ADJUNCTIVE THERAPY IN PATIENTS WITH ALZHEIMERS-DISEASE - A PRACTICAL APPROACH

      Drugs & aging
    65. HANNEKEN A; FRAUTSCHY S; GALASKO D; BAIRD A
      A FIBROBLAST GROWTH-FACTOR BINDING-PROTEIN IN HUMAN CEREBRAL SPINAL-FLUID

      NeuroReport
    66. MOTTER R; VIGOPELFREY C; KHOLODENKO D; BARBOUR R; JOHNSONWOOD K; GALASKO D; CHANG L; MILLER B; CLARK C; GREEN R; OLSON D; SOUTHWICK P; WOLFERT R; MUNROE B; LIEBERBURG I; SEUBERT P; SCHENK D
      REDUCTION OF BETA-AMYLOID PEPTIDE(42), IN THE CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMERS-DISEASE

      Annals of neurology
    67. SAITOH T; XIA Y; CHEN X; MASLIAH E; GALASKO D; SHULTS C; THAL LJ; HANSEN LA; KATZMAN R
      THE CYP2D6B MUTANT ALLELE IS OVERREPRESENTED IN THE LEWY BODY VARIANTOF ALZHEIMERS-DISEASE

      Annals of neurology
    68. KATZMAN R; GALASKO D; SAITOH T; THAL LJ; HANSEN L
      GENETIC-EVIDENCE THAT THE LEWY BODY VARIANT IS INDEED A PHENOTYPIC VARIANT OF ALZHEIMERS-DISEASE

      Brain and cognition
    69. GALASKO D; EDLAND SD; MORRIS JC; CLARK C; MOHS R; KOSS E
      THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD).11. CLINICAL MILESTONES IN PATIENTS WITH ALZHEIMERS-DISEASE FOLLOWEDOVER 3 YEARS

      Neurology
    70. GALASKO D; GOULD R; ABRAMSON I; SALMON DP; KATZMAN R; THAL LJ
      RATE OF COGNITIVE DECLINE IN ALZHEIMERS-DISEASE - RELATIONSHIP TO CLINICAL AND BIOLOGICAL FACTORS

      Neurology
    71. BONDI MW; SALMON DP; MONSCH AU; GALASKO D; BUTTERS N; KATZMAN R; THAL LJ
      EPISODIC MEMORY CHANGES ARE ASSOCIATED WITH THE APOE-EPSILON-4 ALLELEIN NONDEMENTED OLDER ADULTS

      Neurology
    72. OLICHNEY JM; HANSEN LA; GALASKO D; SAITOH T; HOFSTETTER CR; KATZMAN R; THAL LJ
      THE APOLIPOPROTEIN EPSILON-4 ALLELE PROMOTES AMYLOID DEPOSITION IN CEREBRAL BLOOD-VESSELS AND BRAIN IN ALZHEIMERS-DISEASE AND LEWY BODY VARIANT

      Neurology
    73. COREYBLOOM J; THAL LJ; GALASKO D; FOLSTEIN M; DRACHMAN D; RASKIND M; LANSKA DJ
      DIAGNOSIS AND EVALUATION OF DEMENTIA

      Neurology
    74. BONDI MW; SALMON DP; MONSCH AU; GALASKO D; BUTTERS N; KLAUBER MR; THAL LJ; SAITOH T
      EPISODIC MEMORY CHANGES ARE ASSOCIATED WITH THE APOE-EPSILON-4 ALLELEIN NONDEMENTED OLDER ADULTS

      Neurology
    75. MCKEITH IG; GALASKO D; WILCOCK GK; BYRNE EJ
      LEWY BODY DEMENTIA - DIAGNOSIS AND TREATMENT

      British Journal of Psychiatry
    76. OLICHNEY JM; HOFSTETTER CR; GALASKO D; THAL LJ; KATZMAN R
      DEATH CERTIFICATE REPORTING OF DEMENTIA AND MORTALITY IN AN ALZHEIMERS-DISEASE RESEARCH-CENTER COHORT

      Journal of the American Geriatrics Society
    77. HANSEN LA; GALASKO D; SAMUEL W; XIA Y; CHEN XH; SAITOH T
      APOLIPOPROTEIN-E EPSILON-4 IS ASSOCIATED WITH INCREASED NEUROFIBRILLARY PATHOLOGY IN THE LEWY BODY VARIANT OF ALZHEIMERS-DISEASE

      Neuroscience letters
    78. GALASKO D; SAITOH T; XIA Y; KATZMAN R; THAL LJ; HANSEN L
      THE APOLIPOPROTEIN-E E4 ALLELE IS OVER-REPRESENTED IN THE LEWY BODY VARIANT OF ALZHEIMERS-DISEASE

      Neurobiology of aging
    79. THAL LJ; SAITOH T; XIA Y; HANSEN L; GALASKO D; SALMON D; KATZMAN R
      THE APOLIPOPROTEIN-E ALLELE EPSILON-4 IS OVERREPRESENTED IN ALZHEIMER-DISEASE PATIENTS WITH AND WITHOUT LEWY BODIES

      Neurology
    80. GALASKO D; SALMON D; JESTE DV; GRANT I; PAY M; BOWER D; HANSEN L; KATZMAN R; THAL LJ
      HALLUCINATIONS, NOT DEPRESSION OR DELUSIONS, DISTINGUISH PATIENTS WITH AD ACCOMPANIED BY LEWY BODIES FROM PURE AD PATIENTS

      Neurology
    81. ELLIS R; THAL LJ; GALASKO D; COREYBLOOM J; HILL R; HOFSTETTER CR; KATZMAN R
      NEUROLOGIC EXAM FINDINGS IN ALZHEIMERS-DISEASE DURING LONGITUDINAL FOLLOW-UP

      Neurology
    82. GALASKO D; SAITOH T; XIA Y; THAL LJ; KATZMAN R; HILL LR; HANSEN L
      THE APOLIPOPROTEIN-E ALLELE EPSILON-4 IS OVERREPRESENTED IN PATIENTS WITH THE LEWY BODY VARIANT OF ALZHEIMERS-DISEASE

      Neurology
    83. GALASKO D; HANSEN LA; KATZMAN R; WIEDERHOLT W; MASLIAH E; TERRY R; HILL R; LESSIN P; THAL LJ
      CLINICAL-NEUROPATHOLOGICAL CORRELATIONS IN ALZHEIMERS-DISEASE AND RELATED DEMENTIAS

      Archives of neurology
    84. GALASKO D; ABRAMSON I; COREYBLOOM J; THAL LJ
      REPEATED EXPOSURE TO THE MINI-MENTAL-STATE-EXAMINATION AND THE INFORMATION-MEMORY-CONCENTRATION TEST-RESULTS IN A PRACTICE EFFECT IN ALZHEIMERS-DISEASE

      Neurology
    85. GALASKO D; EDLAND S; MORRIS J; CLARK C; MOHS R; KOSS E; THAL LJ
      CLINICAL MILESTONES IN AN ALZHEIMERS-DISEASE (AD) COHORT DURING 2 YEARS OF FOLLOW-UP - THE CERAD EXPERIENCE

      Neurology
    86. THAL LJ; GALASKO D; KATZMAN R; HILL LR; HANSEN L
      CLINICAL NEUROLOGICAL FINDINGS PREDICT LEWY BODIES ASSOCIATED WITH ADAT AUTOPSY

      Neurology
    87. COREYBLOOM J; GALASKO D; THAL L
      DIAGNOSTIC-ACCURACY OF THE STATE OF CALIFORNIA ALZHEIMERS-DISEASE DIAGNOSTIC AND TREATMENT CENTERS CRITERIA FOR ISCHEMIC VASCULAR DEMENTIA

      Neurology
    88. MORRIS JC; EDLAND S; CLARK C; GALASKO D; KOSS E; MOHS R; VANBELLE G; FILLENBAUM G; HEYMAN A
      THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD).4. RATES OF COGNITIVE CHANGE IN THE LONGITUDINAL ASSESSMENT OF PROBABLE ALZHEIMERS-DISEASE

      Neurology
    89. LANGLAIS PJ; THAL L; HANSEN L; GALASKO D; ALFORD M; MASLIAH E
      NEUROTRANSMITTERS IN BASAL GANGLIA AND CORTEX OF ALZHEIMERS-DISEASE WITH AND WITHOUT LEWY BODIES

      Neurology
    90. HANSEN LA; MASLIAH E; GALASKO D; TERRY RD
      PLAQUE-ONLY ALZHEIMER-DISEASE IS USUALLY THE LEWY BODY VARIANT, AND VICE-VERSA

      Journal of neuropathology and experimental neurology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 01:08:02